Health
DR Congo receives over 16,000 Ebola vaccine doses amid surging outbreak
Shipment arrives as health officials confront a fast-moving Bundibugyo virus strain and severe logistical hurdles in conflict areas.
The short version
- The Democratic Republic of the Congo took delivery of 16,250 doses of the Ervebo vaccine to help curb a rapidly expanding Ebola epidemic.
- The current wave is caused by the rare Bundibugyo virus, which currently has no approved vaccine or specific medical treatment.
- More than 2,500 people have died across six provinces as transmission continues to accelerate.
- Additional shipments from a planned 70,000-dose total are slated for delivery in the coming days.
Key facts
- The Democratic Republic of the Congo received an initial shipment of 16,250 Ervebo vaccine doses at N’djili International Airport in Kinshasa.[Associated Press · ABC News]
- The delivery is part of a planned 70,000-dose supply organized by the World Health Organization and partner organizations.[Associated Press · ABC News]
- The outbreak is caused by the rare Bundibugyo virus strain, which lacks a dedicated approved therapy or vaccine.[Associated Press · ABC News]
- Official tallies report between 5,290 and 5,375 confirmed infections and over 2,500 fatalities across six provinces.[Associated Press · ABC News]
- Africa CDC data indicates that the outbreak has not reached its peak and transmission could potentially triple its current pace.[Associated Press · ABC News]
- Response operations face obstacles including rebel conflict, attacks against healthcare workers and facilities, population displacement, and limited infrastructure.[Associated Press · ABC News]
What remains uncertain
- The World Health Organization noted that the Ervebo vaccine may provide cross-protection against the Bundibugyo strain, though its exact degree of efficacy for this variant remains unproven.[Associated Press · ABC News]